acut
respiratori
tract
infect
arti
lead
caus
global
mortal
incid
children
similar
develop
develop
countri
mortal
rate
higher
develop
nearli
children
age
one
four
respiratori
diseas
infant
age
one
requir
virus
etiolog
agent
pathogen
approxim
influenza
viru
iav
influenza
b
viru
ibv
respiratori
syncyti
viru
rsv
parainfluenza
virus
piv
adenoviru
adv
human
metapneumoviru
hmpv
rhinoviru
rv
frequent
report
clinic
differenti
possibl
sinc
symptom
therefor
specif
diagnosi
made
microbiolog
viral
pathogen
detect
viral
cultur
direct
immunofluoresc
test
rapid
antigen
test
andor
nucleic
acid
test
although
viral
cultur
tradit
gold
standard
method
often
slow
technic
demand
caus
problem
patient
manag
direct
immunofluoresc
test
rapid
antigen
assay
produc
result
rel
frame
compar
viral
cultur
howev
sensit
specif
lower
use
specif
nucleic
method
often
prefer
diagnosi
viral
respiratori
infect
especi
hospit
patient
test
quickli
identifi
agent
high
sensit
help
facilit
appropri
manag
patient
infect
control
specif
polymeras
chain
reaction
pcr
monoplex
use
identifi
singl
viral
agent
influenza
ab
rsv
howev
role
limit
multiplex
pcr
test
mpcr
allow
fast
detect
wide
rang
respiratori
virus
therefor
import
use
increas
sever
commerci
studi
aim
assess
role
distribut
characterist
viral
respiratori
agent
children
evalu
mpcr
singl
univers
hospit
last
year
respiratori
tract
sampl
collect
pediatr
patient
arti
symptom
test
viral
pathogen
core
laboratori
dokuz
eylul
univers
hospit
deuh
april
april
children
either
seen
outpati
depart
admit
pediatr
ward
hospit
result
patient
year
age
evalu
retrospect
two
differ
commerci
kit
base
multiplex
pcr
use
studi
period
ausdiagnosticsrespiratori
pathogen
kit
ausdiagnost
beaconsfield
australia
use
april
decemb
fast
track
diagnosticsrespiratori
pathogen
kit
ftd
fast
track
diagnost
junglinst
luxemburg
use
januari
april
ausdiagnost
test
base
multiplex
tandem
pcr
method
identifi
iav
ibv
hmpv
rsv
adv
rhinovirusenteroviru
rvev
bordetella
spp
ftd
test
use
differ
primer
probe
detect
agent
five
reaction
tube
mpcr
agent
iav
iav
subtyp
pandem
ibv
human
rv
human
coronavirus
hcov
hcov
hcov
mycoplasma
pneumonia
human
bocaviru
hbov
hmpvab
rsvab
adv
ev
human
parechoviru
hpev
assay
includ
intern
control
well
neg
posit
run
control
viru
mini
kit
v
qiagen
hamburg
germani
use
nucleic
acid
extract
perform
advanc
xl
qiagen
devic
accord
manufactur
instruct
studi
approv
ethic
committe
research
dokuz
eylul
univers
ref
among
test
sampl
patient
arti
symptom
n
patient
admit
ward
intens
care
unit
n
outpati
studi
sampl
consist
nasopharyng
swab
nasopharyng
aspir
bronchoalveolar
lavag
sampl
among
patient
femal
male
median
age
month
month
sampl
group
accord
age
patient
patient
year
age
group
account
studi
group
year
year
year
age
group
pathogen
detect
studi
sampl
distribut
pcr
posit
sampl
accord
age
group
found
follow
less
year
age
group
year
group
year
group
year
group
posit
rate
decreas
significantli
year
age
p
mean
posit
rate
studi
period
ausdignost
assay
use
compar
second
part
studi
use
fast
track
diagnost
assay
differ
statist
signific
p
figur
rvev
rsv
commonli
detect
agent
follow
iav
tabl
distribut
agent
accord
year
examin
rvev
common
agent
year
rsv
coinfect
took
second
third
place
frequenc
order
except
replac
adv
studi
cover
first
month
coinfect
frequent
caus
respiratori
infect
studi
group
follow
rvev
influenza
ab
respect
figur
distribut
accord
age
group
determin
first
three
pathogen
rvev
rsv
coinfect
less
year
rvev
coinfect
influenza
ab
year
rvev
influenza
ab
coinfect
year
tabl
among
parainfluenza
virus
frequent
detect
subtyp
follow
respect
tabl
bocaviru
posit
case
monoinfect
case
coinfect
case
coinfect
bocavirus
rhinoviru
rsv
influenza
ab
found
frequent
coronavirus
posit
case
monoinfect
case
coinfect
case
hcov
seen
hcov
hcov
patient
coinfect
often
associ
rhinoviru
rsv
posit
result
hpev
studi
period
studi
bordetella
spp
bacteri
agent
test
panel
use
period
detect
total
case
monoinfect
coinfect
major
children
younger
month
preval
coinfect
two
agent
associ
studi
detect
especi
children
age
year
preval
respect
accord
increas
age
group
tabl
rvev
rsv
respons
major
coinfect
figur
frequent
coinfect
rvev
rsv
rvev
adv
rsv
adv
rhinoviru
coronaviru
rhinoviru
bocaviru
rsv
coronaviru
tabl
care
examin
two
differ
distribut
pathogen
determin
first
one
rvev
adv
show
detect
throughout
year
figur
second
one
among
influenza
ab
rsv
hmpv
show
similar
season
distribut
although
shift
month
differ
year
figur
similar
distribut
make
difficult
predict
viru
season
point
import
microbiolog
evalu
accur
diagnosi
although
rvev
detect
month
studi
period
frequenc
increas
octob
novemb
seen
tabl
role
import
respiratori
virus
becom
easili
detect
use
nucleic
test
clinic
laboratori
thu
becam
possibl
obtain
detail
epidemiolog
data
manag
patient
better
studi
retrospect
assess
respiratori
tract
virus
detect
children
arti
symptom
year
two
differ
assay
use
studi
period
ausdiagnost
assay
cover
panel
pathogen
fast
track
assay
test
agent
wider
coverag
pathogen
result
significantli
higher
rate
posit
test
result
studi
rvev
frequent
identifi
pathogen
age
group
everi
year
without
season
differ
use
assay
enabl
separ
rhinoviru
enteroviru
made
possibl
detect
import
rhinoviru
domin
type
rhinovirus
report
frequent
detect
agent
differ
part
world
us
studi
use
commerci
multiplex
test
sampl
taken
pediatr
case
posit
rv
frequent
caus
agent
januari
also
observ
rv
detect
throughout
year
peak
spring
autumn
anoth
studi
scotland
report
rv
common
etiolog
agent
detect
respiratori
tract
sampl
group
patient
median
age
similar
previou
studi
rv
detect
throughout
year
peak
septemb
korean
studi
major
patient
children
also
report
rv
number
one
etiolog
rsv
second
common
viral
agent
rv
studi
particularli
detect
winter
spring
month
peak
januari
march
consist
studi
rsv
observ
frequent
winter
month
mani
studi
differ
rsv
hmpv
usual
seen
children
five
year
age
caus
bronchiol
pneumonia
studi
age
relat
signific
rsv
hmpv
detect
children
year
respect
similar
rsv
hmpv
infect
frequent
seen
winter
spring
month
case
studi
hmpv
case
detect
januari
iav
ibv
detect
frequenc
respect
peak
januari
march
presenc
rsv
hmpv
circul
period
notabl
necessit
use
virolog
method
differenti
diagnosi
ill
ili
circul
respiratori
virus
influenza
season
also
report
refer
laboratori
turkish
public
health
institut
warn
high
possibl
noninfluenza
virus
caus
ili
begin
end
adv
detect
case
mostli
seen
spring
earli
summer
month
although
season
characterist
adenovir
infect
affect
geograph
region
genotyp
viru
infect
report
common
septemb
februari
four
subtyp
piv
may
caus
croup
pharyng
laryng
tracheobronch
bronchiol
andor
commonli
detect
subtyp
studi
follow
detect
frequent
april
may
octob
possibl
detect
season
relat
piv
subtyp
due
small
number
case
studi
also
report
common
subtyp
follow
piv
similar
frequent
detect
spring
earli
summer
month
bocaviru
identifi
isol
respiratori
tract
sampl
children
admit
hospit
due
respiratori
viral
bocaviru
caus
coinfect
case
virus
influenza
rhinoviru
parainfluenza
rsv
preval
bocaviru
studi
coinfect
frequenc
mainli
associ
rhinovirusenteroviru
rsv
influenza
ab
infect
seen
throughout
year
without
clear
season
relat
although
case
januari
march
parallel
report
coronavirus
identifi
nearli
patient
frequent
subtyp
follow
coinfect
rhinoviru
rsv
seen
almost
half
sampl
infect
detect
almost
month
except
june
august
report
coronaviru
infect
peak
mainli
winter
without
signific
differ
four
subtyp
term
season
origin
commun
bordetella
spp
agent
mistaken
viral
infect
sinc
lead
prolong
cough
sever
infect
infant
young
children
patient
bordetella
infect
studi
seen
patient
less
old
except
one
although
seen
age
pertussi
frequent
caus
sever
diseas
children
younger
lack
primari
high
vaccin
coverag
least
necessari
protect
children
diseas
herd
immun
import
herd
immun
nice
describ
italian
studi
three
case
b
pertussi
one
old
two
less
month
old
children
show
reduc
immun
child
famili
year
increas
risk
infect
especi
infant
lack
matern
immun
sever
clinic
present
itali
vaccin
coverag
drop
area
case
report
due
parent
opposit
nucleic
multiplex
test
detect
viral
coinfect
frequent
preval
depend
method
studi
coinfect
detect
sampl
studi
group
preval
decreas
significantli
year
age
p
common
virus
detect
coinfect
rvev
rsv
clinic
import
viral
coinfect
clear
sever
studi
detect
effect
sever
main
limit
studi
retrospect
design
possibl
evalu
effect
multiplex
pcr
assay
patient
manag
sinc
clinic
data
limit
howev
increas
number
test
order
year
suggest
test
result
support
clinic
decis
also
studi
period
allow
better
assess
factor
affect
respiratori
viru
preval
age
season
agent
bocaviru
hcov
bordetella
spp
could
detect
one
two
test
use
studi
therefor
evalu
year
relat
commerci
kit
use
conclus
rvev
group
name
rhinoviru
common
viru
age
group
studi
period
second
commonli
detect
viru
rsv
children
younger
year
age
influenza
ab
children
older
year
age
season
cycl
influenza
viru
well
known
relat
also
seen
rsv
metapneumoviru
virolog
diagnosi
pathogen
import
sinc
three
virus
caus
infect
season
surveil
monitor
annualseason
characterist
respiratori
virus
critic
predict
detect
epidem
pandem
way
would
possibl
diagnos
correct
pathogen
prevent
inappropri
antimicrobi
treatment
author
declar
conflict
interest
